Xeomin® and Gait Related Mobility After Stroke

Recruiting now · Phase 4

Conditions studied: Stroke

In brief

The aim of the present pilot study is to evaluate the association between change in gait related mobility in ambulatory male and female adult hemiparetic patients before and 4-6-weeks after Xeomin® injection into the upper limb, using two standardized tests of physical function in outpatient rehabilitation that are widely used; the 10-meter walk test and the timed 'up and go' test (TUG).

Key facts

Study ID
NCT04908423
Run by
Wake Forest University Health Sciences
People needed
20
Starts
2021-10-19
Expected to finish
2027-04-01
Last updated by the study team
2025-11-25

Who can join

Age: 18 and older, up to 79. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.